Veniti is a pioneering medical device company that has been focused on developing advanced technologies and comprehensive solutions to address the entire spectrum of venous diseases since its founding in 2010. The company's slogan "Pioneering comprehensive solutions for the entire venous disease continuum" reflects its commitment to addressing the complexities of venous disease.
Recognizing the diverse range of conditions related to abnormal or diseased veins, Veniti aims to provide a suite of solutions that range from addressing weakened vein walls to preventing backward blood flow known as reflux. This approach is pivotal in managing chronic venous insufficiency (CVI), venous hypertension, potential clots, and other related issues. The company's flagship product, the VENITI VICI VENOUS STENT® System, is currently being advanced by a team of experts in science, technology, and business.
The most recent milestone for Veniti was a $25.00M Series D investment on 08 September 2016. This signifies a strong vote of confidence from investors in the company's approach to addressing venous diseases. Veniti operates in the Biotechnology and Health Care sectors and is well-positioned to achieve unparalleled results in this dynamic space.
